Synergistic therapeutic actions of herbal ingredients and their mechanisms from molecular interaction and network perspectives

Drug Discovery Today

Volumn 14, Issue 11-12, 2009, Pages 579-588

  Ma, X H ^a   Zheng, C J ^a   Han, L Y ^a   Xie, B ^a   Jia, J ^a   Cao, Z W ^b   Li, Y X ^b   Chen, Y Z ^a,b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b SHANGHAI CENTER FOR BIOINFORMATION TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

5' METHOXYHYDNOCARPIN; ALLYL SULFIDE; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; BERBERINE; BILOBALIDE; CAFFEINE; CATECHIN; DIHYDROKAWAIN; DIHYDROMETHYSTICIN; EMODIN; EPIGALLOCATECHIN GALLATE; GINKGO BILOBA EXTRACT; GINKGOLIDE B; GREEN TEA EXTRACT; HERBACEOUS AGENT; HIRSUTEINE; INDIRUBIN; KAEMPFEROL; KAVA EXTRACT; KAWAIN; MYRICETIN; OSTHOLE; PLACEBO; QUERCETIN; TANSHINONE IIA; TETRASULFIDE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VANILLIN; VENLAFAXINE;

ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANXIETY DISORDER; CANCER SURVIVAL; CHEMICAL COMPOSITION; CLINICAL RESEARCH; CLINICAL TRIAL; COMPLEX FORMATION; CONFORMATIONAL TRANSITION; DRUG BIOAVAILABILITY; DRUG MECHANISM; DRUG POTENTIATION; DRUG RESEARCH; HERBAL MEDICINE; HUMAN; IN VIVO STUDY; MOLECULAR INTERACTION; NONHUMAN; PROMYELOCYTIC LEUKEMIA; REVIEW;

ANIMALS; CLINICAL TRIALS AS TOPIC; DRUG INTERACTIONS; DRUG SYNERGISM; HUMANS; INFORMATION SERVICES; PHYTOTHERAPY; PLANTS, MEDICINAL;

EID: 67349094548     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drudis.2009.03.012     Document Type: Review

References (76)

1. Tausk F.A. Alternative medicine. Is it all in your mind?. Arch. Dermatol. 134 (1998) 1422-1425
2. Beyerstein B.L. Alternative medicine and common errors of reasoning. Acad. Med. 76 (2001) 230-237
3. Lewith G.T., et al. Do attitudes toward and beliefs about complementary medicine affect treatment outcomes?. Am. J. Public Health 92 (2002) 1604-1606
4. Kaptchuk T.J. The placebo effect in alternative medicine: can the performance of a healing ritual have clinical significance?. Ann. Intern. Med. 136 (2002) 817-825
5. Stermitz F.R., et al. Synergy in a medicinal plant: antimicrobial action of berberine potentiated by 5′-methoxyhydnocarpin, a multidrug pump inhibitor. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 1433-1437
6. Williamson E.M. Synergy and other interactions in phytomedicines. Phytomedicine 8 (2001) 401-409
7. Gilbert B., and Alves L.F. Synergy in plant medicines. Curr. Med. Chem. 10 (2003) 13-20
8. Spinella M. The importance of pharmacological synergy in psychoactive herbal medicines. Altern. Med. Rev. 7 (2002) 130-137
9. Ang-Lee M.K., et al. Herbal medicines and perioperative care. J. Am. Med. Assoc. 286 (2001) 208-216
10. Eisenberg D.M., et al. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. J. Am. Med. Assoc. 280 (1998) 1569-1575
11. Bent S. Herbal medicine in the United States: review of efficacy, safety, and regulation: grand rounds at University of California, San Francisco Medical Center. J. Gen. Intern. Med. 23 (2008) 854-859
12. Tsen L.C., et al. Alternative medicine use in presurgical patients. Anesthesiology 93 (2000) 148-151
13. Kaye A.D., et al. Herbal medicines: current trends in anesthesiology practice - a hospital survey. J. Clin. Anesth. 12 (2000) 468-471
14. Wang L., et al. Dissection of mechanisms of Chinese medicinal formula Realgar-Indigo naturalis as an effective treatment for promyelocytic leukaemia. Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 4826-4831
15. Mazza M., et al. Ginkgo biloba and donepezil: a comparison in the treatment of Alzheimer's dementia in a randomized placebo-controlled double-blind study. Eur. J. Neurol. 13 (2006) 981-985
16. Fava M., et al. A double-blind, randomized trial of St John's wort, fluoxetine, and placebo in major depressive disorder. J. Clin. Psychopharmacol. 25 (2005) 441-447
17. Bradwejn J., et al. A double-blind, placebo-controlled study on the effects of Gotu Kola (Centella asiatica) on acoustic startle response in healthy subjects. J. Clin. Psychopharmacol. 20 (2000) 680-684
18. Oh W.K., et al. Prospective, multicenter, randomized phase II trial of the herbal supplement, PC-SPES, and diethylstilbestrol in patients with androgen-independent prostate cancer. J. Clin. Oncol. 22 (2004) 3705-3712
19. Gong X., and Sucher N.J. Stroke therapy in traditional Chinese medicine (TCM): prospects for drug discovery and development. Trends Pharmacol. Sci. 20 (1999) 191-196
20. Lee K.H. Novel antitumor agents from higher plants. Med. Res. Rev. 19 (1999) 569-596
21. Strohl W.R. The role of natural products in a modern drug discovery program. Drug Discov. Today 5 (2000) 39-41
22. Harvey A. Strategies for discovering drugs from previously unexplored natural products. Drug Discov. Today 5 (2000) 294-300
23. Danz H., et al. Quantitative determination of the dual COX-2/5-LOX inhibitor tryptanthrin in Isatis tinctoria by ESI-LC-MS. Planta Med. 68 (2002) 152-157
24. Leonard S.S., et al. Antioxidant properties of fruit and vegetable juices: more to the story than ascorbic acid. Ann. Clin. Lab. Sci. 32 (2002) 193-200
25. Scholey A.B., and Kennedy D.O. Acute, dose-dependent cognitive effects of Ginkgo biloba, Panax ginseng and their combination in healthy young volunteers: differential interactions with cognitive demand. Hum. Psychopharmacol. 17 (2002) 35-44
26. Greco W.R., et al. The search for synergy: a critical review from a response surface perspective. Pharmacol. Rev. 47 (1995) 331-385
27. Jia J., et al. Mechanisms of drug combinations from interaction and network perspectives. Nat. Rev. Drug Discov. 8 (2009) 111-128
28. Kumar N., et al. Multipathway model enables prediction of kinase inhibitor cross-talk effects on migration of Her2-overexpressing mammary epithelial cells. Mol. Pharmacol. 73 (2008) 1668-1678
29. Conte A., et al. Synergistic protection of PC12 cells from beta-amyloid toxicity by resveratrol and catechin. Brain Res. Bull. 62 (2003) 29-38
30. Morre D.J., and Morre D.M. Synergistic Capsicum-tea mixtures with anticancer activity. J. Pharm. Pharmacol. 55 (2003) 987-994
31. Chou T.C. Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies. Pharmacol. Rev 58 (2006) 621-681
32. Jayanthi L.D., and Ramamoorthy S. Regulation of monoamine transporters: influence of psychostimulants and therapeutic antidepressants. AAPS J. 7 (2005) E728-738
33. Kopin I.J. Monoamine oxidase and catecholamine metabolism. J. Neural Transm. Suppl. 41 (1994) 57-67
34. Oechsner M., et al. COMT-inhibition increases serum levels of dihydroxyphenylacetic acid (DOPAC) in patients with advanced Parkinson's disease. J. Neural Transm. 109 (2002) 69-75
35. Jabbi M., et al. Convergent genetic modulation of the endocrine stress response involves polymorphic variations of 5-HTT, COMT and MAOA. Mol. Psychiatry 12 (2007) 483-490
36. Canter P.H., and Ernst E. Ginkgo biloba is not a smart drug: an updated systematic review of randomised clinical trials testing the nootropic effects of G. biloba extracts in healthy people. Hum. Psychopharmacol. 22 (2007) 265-278
37. Combs C.K., et al. beta-Amyloid stimulation of microglia and monocytes results in TNFalpha-dependent expression of inducible nitric oxide synthase and neuronal apoptosis. J. Neurosci. 21 (2001) 1179-1188
38. Kuhn D.J., et al. Direct inhibition of the ubiquitin-proteasome pathway by ester bond-containing green tea polyphenols is associated with increased expression of sterol regulatory element-binding protein 2 and LDL receptor. Biochim. Biophys. Acta 1682 (2004) 1-10
39. Chandrasekaran K., et al. Bilobalide, a component of the Ginkgo biloba extract (EGb 761), protects against neuronal death in global brain ischemia and in glutamate-induced excitotoxicity. Cell Mol. Biol. (Noisy-le-grand) 48 (2002) 663-669
40. Mix J.A., and Crews W.D.J. A double-blind, placebo-controlled, randomized trial of Ginkgo biloba extract EGb 761 in a sample of cognitively intact older adults: neuropsychological findings. Hum. Psychopharmacol. 17 (2002) 267-277
41. Kirsch J. Glycinergic transmission. Cell Tissue Res. 326 (2006) 535-540
42. Kiewert C., et al. Role of GABAergic antagonism in the neuroprotective effects of bilobalide. Brain Res. 1128 (2007) 70-78
43. Huang S.H., et al. Mixed antagonistic effects of bilobalide at rho1 GABAC receptor. Neuroscience 137 (2006) 607-617
44. Defeudis F.V. Bilobalide and neuroprotection. Pharmacol. Res. 46 (2002) 565-568
45. Kondratskaya E.L., et al. Ginkgolide B preferentially blocks chloride channels formed by heteromeric glycine receptors in hippocampal pyramidal neurons of rat. Brain Res. Bull. 63 (2004) 309-314
46. Lynch J.W., et al. Building new function into glycine receptors: a structural model for the activation of the glycine-gated chloride channel. Clin. Exp. Pharmacol. Physiol. 26 (1999) 932-934
47. Li P., and Slaughter M. Glycine receptor subunit composition alters the action of GABA antagonists. Vis. Neurosci. 24 (2007) 513-521
48. Dryden M.S., et al. A randomized, controlled trial of tea tree topical preparations versus a standard topical regimen for the clearance of MRSA colonization. J. Hosp. Infect. 56 (2004) 283-286
49. Blanco A.R., et al. Epigallocatechin gallate inhibits biofilm formation by ocular staphylococcal isolates. Antimicrob. Agents Chemother. 49 (2005) 4339-4343
50. Gradisar H., et al. Green tea catechins inhibit bacterial DNA gyrase by interaction with its ATP binding site. J. Med. Chem. 50 (2007) 264-271
51. Jodoin J., et al. Inhibition of the multidrug resistance P-glycoprotein activity by green tea polyphenols. Biochim. Biophys. Acta 1542 (2002) 149-159
52. Hong J., et al. Stability, cellular uptake, biotransformation, and efflux of tea polyphenol (-)-epigallocatechin-3-gallate in HT-29 human colon adenocarcinoma cells. Cancer Res. 62 (2002) 7241-7246
53. Yata N., et al. Enhanced small intestinal absorption of beta-lactam antibiotics in rats in the presence of monodesmosides isolated from pericarps of Sapindus mukurossi (Enmei-hi). J. Pharmacobiodyn. 9 (1986) 211-217
54. Butterweck V., et al. Solubilized hypericin and pseudohypericin from Hypericum perforatum exert antidepressant activity in the forced swimming test. Planta Med. 64 (1998) 291-294
55. Butterweck V., et al. Plasma levels of hypericin in presence of procyanidin B2 and hyperoside: a pharmacokinetic study in rats. Planta Med. 69 (2003) 189-192
56. Fakruddin J.M., and Laurence J. Interactions among human immunodeficiency virus (HIV)-1, interferon-gamma and receptor of activated NF-kappa B ligand (RANKL): implications for HIV pathogenesis. Clin. Exp. Immunol. 137 (2004) 538-545
57. Quiney C., et al. Pro-apoptotic properties of hyperforin in leukemic cells from patients with B-cell chronic lymphocytic leukemia. Leukemia 20 (2006) 491-497
58. Nieminen A.I., et al. c-Myc blazing a trail of death: coupling of the mitochondrial and death receptor apoptosis pathways by c-Myc. Cell Cycle 6 (2007) 2464-2472
59. Amir H., et al. Lycopene and 1,25-dihydroxyvitamin D3 cooperate in the inhibition of cell cycle progression and induction of differentiation in HL-60 leukemic cells. Nutr. Cancer 33 (1999) 105-112
60. Nahum A., et al. Lycopene inhibition of cell cycle progression in breast and endometrial cancer cells is associated with reduction in cyclin D levels and retention of p27(Kip1) in the cyclin E-cdk2 complexes. Oncogene 20 (2001) 3428-3436
61. Lu J., et al. Transcriptional profiling of keratinocytes reveals a vitamin D-regulated epidermal differentiation network. J. Invest. Dermatol. 124 (2005) 778-785
62. Eelen G., et al. Mechanism and potential of the growth-inhibitory actions of vitamin D and analogs. Curr. Med. Chem. 14 (2007) 1893-1910
63. Malinen M., et al. Distinct HDACs regulate the transcriptional response of human cyclin-dependent kinase inhibitor genes to Trichostatin A and 1alpha, 25-dihydroxyvitamin D3. Nucleic Acids Res. 36 (2008) 121-132
64. Kawashima K., et al. Pharmacological properties of traditional medicine (XXIX): effect of Hange-shashin-to and the combinations of its herbal constituents on rat experimental colitis. Biol. Pharm. Bull. 27 (2004) 1599-1603
65. Neuman M.G. Immune dysfunction in inflammatory bowel disease. Transl. Res. 149 (2007) 173-186
66. Park J.S., et al. Anti-inflammatory mechanism of ginseng saponins in activated microglia. J. Neuroimmunol. (2009)
67. Takei H., et al. Glycyrrhizin inhibits interleukin-8 production and nuclear factor-kappaB activity in lung epithelial cells, but not through glucocorticoid receptors. J. Pharmacol. Sci. 106 (2008) 460-468
68. Kiyohara H., et al. Combination effects of herbs in a multi-herbal formula: expression of Juzen-taiho-to's immuno-modulatory activity on the intestinal immune system. Evid. Based Complement Alternat. Med. 1 (2004) 83-91
69. Howes M.J., and Houghton P.J. Plants used in Chinese and Indian traditional medicine for improvement of memory and cognitive function. Pharmacol. Biochem. Behav. 75 (2003) 513-527
70. Zhuang Y., et al. Can the aggregation be a new approach for understanding the mechanism of Traditional Chinese Medicine?. J. Ethnopharmacol. 117 (2008) 378-384
71. Xia X.F., and Sui S.F. The membrane insertion of trichosanthin is membrane-surface-pH dependent. Biochem. J. 349 Pt 3 (2000) 835-841
72. Zhang L., et al. Intestinal and hepatic glucuronidation of flavonoids. Mol. Pharm. 4 (2007) 833-845
73. Lin J.C., et al. Inhibitory effects of some derivatives of glycyrrhizic acid against Epstein-Barr virus infection: structure-activity relationships. Antiviral Res. 79 (2008) 6-11
74. Mak D.H., et al. Dang-Gui Buxue Tang produces a more potent cardioprotective effect than its component herb extracts and enhances glutathione status in rat heart mitochondria and erythrocytes. Phytother. Res. 20 (2006) 561-567
75. Dong T.T., et al. Chemical and biological assessment of a Chinese herbal decoction containing Radix Astragali and Radix Angelicae Sinensis: determination of drug ratio in having optimized properties. J. Agric. Food Chem. 54 (2006) 2767-2774
76. He F., and Luo J.B. Effect on pharmacokinetics of pseudo-ephedrine in human plasma among herbs in Mahuang decoction. Zhongguo Zhong Yao Za Zhi 30 (2005) 1454-1457